Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 apraglutide versus placebo in adults with short bowel syndrome-associated intestinal failure
MOH_2021-05-24_009992Phase 3Not yet recruiting
- Sponsor
- VectivBio
- Start
- May 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in short bowel syndrome (SBS) comparing Apraglutide with Placebo (2 arms). Planned start May 2021; status: not yet recruiting.
02
Drugs
apraglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on MOH_2021-05-24_009992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-05-24_009992.